ImmunityBio, Inc. (IBRX)
6.085
-0.48
(-7.38%)
USD |
NASDAQ |
Nov 20, 15:51
ImmunityBio 30-Day Average Daily Volume : 14.37M for Nov. 19, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| November 19, 2026 | 14.37M |
| November 18, 2026 | 14.35M |
| November 17, 2026 | 14.22M |
| November 16, 2026 | 14.40M |
| November 13, 2026 | 14.53M |
| November 12, 2026 | 15.13M |
| November 11, 2026 | 14.84M |
| November 10, 2026 | 15.35M |
| November 09, 2026 | 14.96M |
| November 06, 2026 | 13.81M |
| November 05, 2026 | 13.70M |
| November 04, 2026 | 13.58M |
| November 03, 2026 | 13.71M |
| November 02, 2026 | 14.21M |
| October 30, 2026 | 14.32M |
| October 29, 2026 | 14.63M |
| October 28, 2026 | 15.03M |
| October 27, 2026 | 15.10M |
| October 26, 2026 | 15.05M |
| October 23, 2026 | 14.99M |
| October 22, 2026 | 15.21M |
| October 21, 2026 | 15.07M |
| October 20, 2026 | 15.01M |
| October 19, 2026 | 14.79M |
| October 16, 2026 | 14.29M |
| Date | Value |
|---|---|
| October 15, 2026 | 13.74M |
| October 14, 2026 | 13.32M |
| October 13, 2026 | 12.53M |
| October 12, 2026 | 12.37M |
| October 09, 2026 | 12.27M |
| October 08, 2026 | 12.06M |
| October 07, 2026 | 12.02M |
| October 06, 2026 | 12.01M |
| October 05, 2026 | 11.64M |
| October 02, 2026 | 11.33M |
| October 01, 2026 | 10.56M |
| September 30, 2026 | 10.58M |
| September 29, 2026 | 9.855M |
| September 28, 2026 | 9.803M |
| September 25, 2026 | 9.620M |
| September 24, 2026 | 9.626M |
| September 23, 2026 | 9.505M |
| September 22, 2026 | 9.207M |
| September 21, 2026 | 8.703M |
| September 18, 2026 | 8.608M |
| September 17, 2026 | 8.253M |
| September 16, 2026 | 7.998M |
| September 15, 2026 | 8.325M |
| September 14, 2026 | 8.318M |
| September 11, 2026 | 8.325M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Moderna, Inc. | 14.61M |
| Sarepta Therapeutics, Inc. | 2.419M |
| Oncolytics Biotech, Inc. | 1.369M |
| Sangamo Therapeutics, Inc. | 1.137M |
| Anixa Biosciences, Inc. | 196366.9 |